Forte Biosciences Inc. (FBRX)
undefined
undefined%
At close: undefined
23.15
-1.59%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -31.48M -13.88M -21.71M -46.49M -4.07M -48.95M -38.93M -33.48M -23.06M
Depreciation & Amortization 9.00K - 36.00K 54.00K 11.00K 625.00K 292.00K 255.00K 232.00K
Stock-Based Compensation 3.28M 4.01M 4.21M 956.00K 35.71K 6.87M 4.45M - -
Other Working Capital -663.00K 1.47M 1.01M -3.46M 274.84K 4.82M 2.21M 1.28M 176.00K
Other Non-Cash Items -131.00K 3.81M 61.00K 30.89M -918.00K 7.77M 5.26M 1.74M 928.00K
Deferred Income Tax - - - - 918.00K -6.87M -4.45M - -
Change in Working Capital -392.00K 1.68M 720.00K -3.83M 1.25M 6.08M 2.52M 1.87M 747.00K
Operating Cash Flow -28.71M -8.19M -16.68M -18.42M -2.77M -34.47M -31.13M -29.54M -21.04M
Capital Expenditures -88.00K - - - -161.60K -1.97M -655.00K -525.00K -231.00K
Acquisitions - - - 3.58K - 2.22M 20.00K - 15.00K
Purchase of Investments -9.96M - - - - -70.75M -70.80M -23.00M -59.87M
Sales Maturities Of Investments 10.10M - - - - 68.52M 43.73M 48.09M 35.16M
Other Investing Acitivies - - - 3.58M 42.32M -2.22M -27.05M 25.09M -24.70M
Investing Cash Flow 47.00K - - 3.58M -161.60K -4.19M -27.71M 24.57M -24.93M
Debt Repayment - - - - - 23.32M 138.00K 2.91M 50.74M
Common Stock Repurchased - - - - - - 89.00K 3.38M 33.23M
Dividend Paid - - - - - - - - -
Other Financial Acitivies -28.00K 12.00K -44.00K -32.00K 4.86M -8.63M - -592.00K -982.00K
Financial Cash Flow 24.68M 7.24M -44.00K 66.67M 4.86M 43.54M 89.26M 2.33M 49.92M
Net Cash Flow -3.98M -944.00K -16.72M 51.83M 1.92M 4.88M 30.42M -2.64M 3.95M
Free Cash Flow -28.79M -8.19M -16.68M -18.42M -2.93M -36.44M -31.79M -30.06M -21.27M